A Phase 1b Study of Gemcitabine and Nab-paclitaxel in Combination With IM156 in Patients With Advanced Pancreatic Cancer.
Clinical trial NCT05497778 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05497778
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-21
- Primary completion
- 2027-02-02
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.